Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Lifestyle1966 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A03379 | 34024536 | Clin Nutr ESPEN | Telemedicine as a tool for dietary intervention in NAFLD-HIV patients during the COVID-19 lockdown: A randomized controlled trial. | 2021 | Details |
| A03386 | 34022107 | Liver Int | A Twitter discourse analysis of negative feelings and stigma related to NAFLD, NASH and obesity. | 2021 | Details |
| A03387 | 34020377 | Comput Methods Programs Biomed | Training of computational algorithms to predict NAFLD activity score and fibrosis stage from liver histopathology slides. | 2021 | Details |
| A03391 | 34019353 | Vopr Pitan | [Specialized products for dietary correction of the diet of patients with non-alcoholic steatohepatitis]. | 2021 | Details |
| A03420 | 34006994 | Eur J Clin Nutr | Non-alcoholic fatty liver disease in obese children and adolescents: a role for nutrition? | 2021 | Details |
| A03437 | 34001005 | BMC Gastroenterol | Association of meat consumption with NAFLD risk and liver-related biochemical indexes in older Chinese: a cross-sectional study. | 2021 | Details |
| A03459 | 33993460 | Drugs Real World Outcomes | Correlation of Objective Endpoints and Subjective Patient-Reported Outcomes in NAFLD Treatment with Essential Phospholipids: Real-World Data Based on Pooled Analysis of Observational Studies. | 2021 | Details |
| A03482 | 33987427 | Ann Transl Med | Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention. | 2021 | Details |
| A03484 | 33987424 | Ann Transl Med | Non-alcoholic fatty liver diseases: current challenges and future directions. | 2021 | Details |
| A03498 | 33982400 | Liver Int | Clinical impact of sexual dimorphism in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). | 2021 | Details |
| A03522 | 33971815 | BMC Gastroenterol | Normalization of γ-glutamyl transferase levels is associated with better metabolic control in individuals with nonalcoholic fatty liver disease. | 2021 | Details |
| A03565 | 33952449 | Anticancer Res | Obesity and Liver Cancer in Japan: A Comprehensive Review. | 2021 | Details |
| A03569 | 33951121 | J Gastrointestin Liver Dis | Association between Sarcopenic Obesity and Nonalcoholic Fatty Liver Disease and Fibrosis detected by Fibroscan. | 2021 | Details |
| A03589 | 33939897 | J Pediatr Endocrinol Metab | Effect of l-carnitine supplementation on children and adolescents with nonalcoholic fatty liver disease (NAFLD): a randomized, triple-blind, placebo-controlled clinical trial. | 2021 | Details |
| A03592 | 33939147 | Dig Dis Sci | Impact of a Pilot Structured Mobile Technology Based Lifestyle Intervention for Patients with Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A03596 | 33938135 | Liver Int | Effects of lifestyle interventions on epigenetic signatures of liver fat: Central randomized controlled trial. | 2021 | Details |
| A03597 | 33937307 | Front Nutr | Variation in Lifestyle-Related Behavior Among Obese Indian Patients With Non-alcoholic Fatty Liver Disease. | 2021 | Details |
| A03600 | 33937257 | Front Cell Dev Biol | Autophagy in Hepatic Steatosis: A Structured Review. | 2021 | Details |
| A03610 | 33932796 | Clin Nutr | Beverages and Non-alcoholic fatty liver disease (NAFLD): Think before you drink. | 2021 | Details |
| A03621 | 33927697 | Front Endocrinol (Lausanne) | Efficacy of Weight Reduction on Pediatric Nonalcoholic Fatty Liver Disease: Opportunities to Improve Treatment Outcomes Through Pharmacotherapy. | 2021 | Details |
| A03638 | 33923255 | Nutrients | Overview of Non-Alcoholic Fatty Liver Disease (NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components in Its Development. | 2021 | Details |
| A03641 | 33922278 | Genes (Basel) | The Effect of Genetic Polymorphism in Response to Body Weight Reduction in Japanese Patients with Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A03650 | 33920670 | Int J Mol Sci | Remodeling of Mitochondrial Plasticity: The Key Switch from NAFLD/NASH to HCC. | 2021 | Details |
| A03653 | 33918878 | Int J Mol Sci | Nonalcoholic Fatty Liver Disease: Focus on New Biomarkers and Lifestyle Interventions. | 2021 | Details |
| A03670 | 33912410 | Tzu Chi Med J | Role of diet and lifestyle modification in the management of nonalcoholic fatty liver disease and type 2 diabetes. | 2020 | Details |
| A03699 | 33898961 | JHEP Rep | Physical activity is associated with reduced risk of liver disease in the prospective UK Biobank cohort. | 2021 | Details |
| A03700 | 33898960 | JHEP Rep | Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet - a randomised controlled trial. | 2021 | Details |
| A03716 | 33894145 | Lancet | Non-alcoholic fatty liver disease. | 2021 | Details |
| A03727 | 33889132 | Front Endocrinol (Lausanne) | Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes. | 2021 | Details |
| A03756 | 33875327 | Trends Endocrinol Metab | RIPK1 targeting protects against obesity and atherosclerosis. | 2021 | Details |
| A03759 | 33872646 | Environ Res | Serum selenium and non-alcoholic fatty liver disease (NAFLD) in U.S. adults: National Health and Nutrition Examination Survey (NHANES) 2011-2016. | 2021 | Details |
| A03804 | 33860188 | ACS Pharmacol Transl Sci | Pyruvate Dehydrogenase as a Therapeutic Target for Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A03831 | 33854987 | J Hepatocell Carcinoma | NAFLD-Associated HCC: Progress and Opportunities. | 2021 | Details |
| A03855 | 33844928 | Child Obes | Omega-3 Use for the Treatment of Hypertriglyceridemia, Low High-Density Lipoprotein Cholesterol Levels, and Nonalcoholic Fatty Liver Disease in Children with Obesity. | 2021 | Details |
| A03865 | 33839905 | Eur J Nutr | Improving insulin sensitivity, liver steatosis and fibrosis in type 2 diabetes by a food-based digital education-assisted lifestyle intervention program: a feasibility study. | 2021 | Details |
| A03868 | 33838994 | Nutr Metab Cardiovasc Dis | Does a high intake of green leafy vegetables protect from NAFLD? Evidence from a large population study. | 2021 | Details |
| A03875 | 33837275 | Eur J Clin Nutr | Higher plain water intake is related to lower newly diagnosed nonalcoholic fatty liver disease risk: a population-based study. | 2021 | Details |
| A03876 | 33836983 | J Clin Lipidol | Managing cardiometabolic risk factors across a woman's lifespan: A lipidologist's perspective. | 2021 | Details |
| A03878 | 33834607 | Liver Transpl | Reduction of Visceral Adiposity as a Predictor for Resolution of Nonalcoholic Fatty Liver in Potential Living Liver Donors. | 2021 | Details |
| A03884 | 33833450 | Nat Rev Cardiol | Global epidemiology of dyslipidaemias. | 2021 | Details |
| A03957 | 33808036 | Biomolecules | Intracellular Toxic AGEs (TAGE) Triggers Numerous Types of Cell Damage. | 2021 | Details |
| A03968 | 33806527 | Pharmaceuticals (Basel) | The Evaluation of Drug Delivery Nanocarrier Development and Pharmacological Briefing for Metabolic-Associated Fatty Liver Disease (MAFLD): An Update. | 2021 | Details |
| A03992 | 33799862 | Int J Mol Sci | A Scoping Review on Lipocalin-2 and Its Role in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma. | 2021 | Details |
| A04012 | 33789150 | J Nutr Biochem | The transcription factors CREBH, PPARa, and FOXO1 as critical hepatic mediators of diet-induced metabolic dysregulation. | 2021 | Details |
| A04017 | 33788206 | Semin Liver Dis | Wearables, Physical Activity, and Exercise Testing in Liver Disease. | 2021 | Details |
| A04037 | 33780425 | MEDICC Rev | Non-Alcoholic Fatty Liver Disease in Cuba. | 2021 | Details |
| A04042 | 33777980 | Front Med (Lausanne) | Dynamic Chronological Changes in Serum Triglycerides Are Associated With the Time Point for Non-alcoholic Fatty Liver Disease Development in the Nationwide Korean Population Cohort. | 2021 | Details |
| A04051 | 33776366 | World J Gastroenterol | Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease. | 2021 | Details |
| A04063 | 33772456 | Indian J Gastroenterol | Efficacy of combining pentoxiphylline and vitamin E versus vitamin E alone in non-alcoholic steatohepatitis- A randomized pilot study. | 2021 | Details |
| A04068 | 33771699 | Pharmacol Res | Epigenetics in NAFLD/NASH: Targets and therapy. | 2021 | Details |
| A04079 | 33767944 | Curr Hepatol Rep | Exercise as Medicine: The Impact of Exercise Training on Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A04083 | 33766176 | Br J Nutr | 'Focus on diet quality': a qualitative study of clinicians' perspectives of use of the Mediterranean dietary pattern for non-alcoholic fatty liver disease. | 2021 | Details |
| A04177 | 33727164 | Clin Gastroenterol Hepatol | Effect of Endoscopic Bariatric and Metabolic Therapies on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. | 2021 | Details |
| A04194 | 33720580 | Ter Arkh | [Mixed steatohepatitis: more questions than answers (Part 1)]. | 2020 | Details |
| A04200 | 33718398 | Front Med (Lausanne) | Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review. | 2021 | Details |
| A04212 | 33711631 | Clin Res Hepatol Gastroenterol | The Ability of the Framingham Steatosis Index (FSI) to Predict Non-alcoholic Fatty Liver Disease (NAFLD): A Cohort Study. | 2021 | Details |
| A04234 | 33703947 | J Appl Physiol (1985) | High fat high sucrose diet-induced dyslipidemia in guinea pigs. | 2021 | Details |
| A04274 | 33680375 | Caspian J Intern Med | Recurrence of fatty liver disease following liver transplantation for NAFLD-related cirrhosis: Current status and challenges. | 2020 | Details |
| A04276 | 33679874 | Front Genet | Associations Among Methylene Tetrahydrofolate Reductase rs1801133 C677T Gene Variant, Food Groups, and Non-alcoholic Fatty Liver Disease Risk in the Chinese Population. | 2021 | Details |
| A04301 | 33672073 | Nutrients | Energy Expenditure Improved Risk Factors Associated with Renal Function Loss in NAFLD and MetS Patients. | 2021 | Details |
| A04325 | 33665203 | Front Nutr | The Impact of Macronutrient Intake on Non-alcoholic Fatty Liver Disease (NAFLD): Too Much Fat, Too Much Carbohydrate, or Just Too Many Calories? | 2021 | Details |
| A04349 | 33652942 | Int J Mol Sci | Treatments for NAFLD: State of Art. | 2021 | Details |
| A04387 | 33639080 | Int J Med Mushrooms | In Vitro Antioxidation, Antihepatic Steatosis, and Anti-Inflammatory Effects of Ethyl Acetate Fraction from Auricularia nigricans (Agaricomycetes). | 2021 | Details |
| A04397 | 33634772 | Public Health Nutr | Higher Healthy Lifestyle Score is associated with lower presence of non-alcoholic fatty liver disease in middle-aged and older Chinese adults: a community-based cross-sectional study. | 2021 | Details |
| A04401 | 33632126 | BMC Gastroenterol | Diagnostic accuracy assessment of molecular prediction model for the risk of NAFLD based on MRI-PDFF diagnosed Chinese Han population. | 2021 | Details |
| A04409 | 33630217 | Dig Dis Sci | Cadmium Exposure in Young Adulthood Is Associated with Risk of Nonalcoholic Fatty Liver Disease in Midlife. | 2021 | Details |
| A04412 | 33628758 | Can J Gastroenterol Hepatol | Metabolic and Hepatic Effects of Energy-Reduced Anti-Inflammatory Diet in Younger Adults with Obesity. | 2021 | Details |
| A04445 | 33614318 | Cureus | Treatment of Fatty Liver Disease: The Present and the Future. | 2021 | Details |
| A04446 | 33613940 | Frontline Gastroenterol | Evaluation of a primary to secondary care referral pathway and novel nurse-led one-stop clinic for patients with suspected non-alcoholic fatty liver disease. | 2020 | Details |
| A04458 | 33608323 | Dis Model Mech | High-dose vitamin B1 therapy prevents the development of experimental fatty liver driven by overnutrition. | 2021 | Details |
| A04487 | 33599159 | Expert Opin Pharmacother | An update on pharmacotherapeutic strategies for obesity. | 2021 | Details |
| A04491 | 33597924 | Front Endocrinol (Lausanne) | The Role of Lipophagy in the Development and Treatment of Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A04493 | 33597074 | Clin Ther | Advances in the Epidemiology, Diagnosis, and Management of Pediatric Fatty Liver Disease. | 2021 | Details |
| A04546 | 33583577 | Clin Ther | Therapy for Nonalcoholic Fatty Liver Disease: Current Options and Future Directions. | 2021 | Details |
| A04565 | 33578702 | Antioxidants (Basel) | Mechanisms of Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome. A Narrative Review. | 2021 | Details |
| A04585 | 33572797 | Cancers (Basel) | The Current View of Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma. | 2021 | Details |
| A04604 | 33566371 | FASEB J | NUPR1 protects liver from lipotoxic injury by improving the endoplasmic reticulum stress response. | 2021 | Details |
| A04608 | 33564868 | Am J Clin Nutr | Soft drink consumption and risk of nonalcoholic fatty liver disease: results from the Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIH) cohort study. | 2021 | Details |
| A04632 | 33557031 | Life (Basel) | Adiposity in Depression or Depression in Adiposity? The Role of Immune-Inflammatory-Microbial Overlap. | 2021 | Details |
| A04641 | 33554097 | JHEP Rep | Non-alcoholic fatty liver disease does not increase dementia risk although histology data might improve risk prediction. | 2020 | Details |
| A04644 | 33553966 | Hepatol Commun | Nonalcoholic Fatty Liver Disease Screening in Type 2 Diabetes Mellitus Patients in the Primary Care Setting. | 2020 | Details |
| A04652 | 33550706 | Liver Int | Effects of two personalized dietary strategies during a 2-year intervention in subjects with nonalcoholic fatty liver disease: A randomized trial. | 2021 | Details |
| A04663 | 33548123 | J Gastrointestin Liver Dis | Vegan Diet Advice Might Benefit Liver Enzymes in Nonalcoholic Fatty Liver Disease: an Open Observational Pilot Study. | 2021 | Details |
| A04668 | 33546191 | Biomedicines | Insights into the Impact of Microbiota in the Treatment of NAFLD/NASH and Its Potential as a Biomarker for Prognosis and Diagnosis. | 2021 | Details |
| A04671 | 33546051 | Medicine (Baltimore) | Comparative efficacy and safety of traditional Chinese patent medicine for NAFLD in childhood or adolescence: A protocol for a Bayesian network meta analysis. | 2021 | Details |
| A04699 | 33536048 | Nutr Metab (Lond) | Effectiveness of companion-intensive multi-aspect weight management in Chinese adults with obesity: a 6-month multicenter randomized clinical trial. | 2021 | Details |
| A04702 | 33535220 | J Vasc Res | Pyridoxamine and Caloric Restriction Improve Metabolic and Microcirculatory Abnormalities in Rats with Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A04716 | 33530440 | J Clin Med | NAFLD and Cardiovascular Diseases: Epidemiological, Mechanistic and Therapeutic Considerations. | 2021 | Details |
| A04724 | 33527637 | Liver Int | National digestive disease specialists survey on cardiovascular risk management in non-alcoholic fatty liver disease in spanish hospitals. | 2021 | Details |
| A04726 | 33526312 | Clin Ther | Nonalcoholic Fatty Liver Disease: A Global Perspective. | 2021 | Details |
| A04735 | 33520810 | J Diabetes Metab Disord | Lifestyle and silymarin: a fight against liver damage in NAFLD associated - prediabetic disease. | 2020 | Details |
| A04740 | 33518166 | Gastroenterol Clin North Am | The Impact of Dietary Patterns and Nutrition in Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A04773 | 33511092 | Front Pediatr | Childhood and Adolescent Obesity: A Review. | 2021 | Details |
| A04783 | 33506572 | Liver Int | Fibroblast Growth Factor 19: Potential modulation of hepatic metabolism for the treatment of non-alcoholic fatty liver disease. | 2021 | Details |
| A04831 | 33490936 | JHEP Rep | Ketohexokinase inhibition improves NASH by reducing fructose-induced steatosis and fibrogenesis. | 2020 | Details |
| A04832 | 33490935 | JHEP Rep | (13C)-Methacetin breath test provides evidence of subclinical liver dysfunction linked to fat storage but not lifestyle. | 2020 | Details |
| A04846 | 33486083 | Clin Gastroenterol Hepatol | Weight Loss and Weight Regain in Usual Clinical Practice: Results From the TARGET-NASH Observational Cohort. | 2021 | Details |
| A04865 | 33476465 | Clin Transl Sci | Critical need for pharmacologic treatment options in NAFLD: A pediatric perspective. | 2021 | Details |
| A04868 | 33475559 | J Pak Med Assoc | Non-alcoholic fatty liver disease: A real threat in Pakistan. | 2020 | Details |
| A04871 | 33474638 | Eur J Nutr | Differential response to a 6-month energy-restricted treatment depending on SH2B1 rs7359397 variant in NAFLD subjects: Fatty Liver in Obesity (FLiO) Study. | 2021 | Details |